Bristol-Myers Squibb Company
BMY
$59.01
-$1.27-2.11%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
--
EPS (TTM)
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 3.78% | -2.53% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.78% | -2.53% | |||
| Cost of Revenue | 12.46% | -3.87% | |||
| Gross Profit | 1.04% | -2.10% | |||
| SG&A Expenses | -10.96% | 8.28% | |||
| Depreciation & Amortization | -29.63% | -0.41% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.55% | 0.96% | |||
| Operating Income | 27.31% | -15.43% | |||
| Income Before Tax | -89.56% | 30.33% | |||
| Income Tax Expenses | -78.52% | 215.83% | |||
| Earnings from Continuing Operations | -93.74% | -27.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | 0.00% | |||
| Net Income | -94.05% | -27.92% | |||
| EBIT | 27.31% | -15.43% | |||
| EBITDA | -3.79% | -7.53% | |||
| EPS Basic | -94.05% | -27.96% | |||
| Normalized Basic EPS | 5.62% | -12.21% | |||
| EPS Diluted | -94.05% | -27.96% | |||
| Normalized Diluted EPS | 5.37% | -12.24% | |||
| Average Basic Shares Outstanding | 0.05% | 0.05% | |||
| Average Diluted Shares Outstanding | 0.30% | 0.10% | |||
| Dividend Per Share | 3.33% | 0.00% | |||
| Payout Ratio | 15.85% | 0.39% | |||
